Literature DB >> 9442893

Genetics of prions.

S B Prusiner1, M R Scott.   

Abstract

Prions are unprecedented infectious pathogens that cause a group of invariably fatal, neurodegenerative diseases by an entirely novel mechanism. Prion diseases may present as genetic, infectious, or sporadic disorders, all of which involve modification of the prion protein (PrP). The human prion disease Creutzfeldt-Jakob disease (CJD) generally presents as a progressive dementia, whereas scrapie of sheep and bovine spongiform encephalopathy (BSE) are manifest as ataxic illnesses. Prions are devoid of nucleic acid and seem to be composed exclusively of a modified isoform of PrP designated PrPSc. The normal, cellular PrP designated PrPC is converted into PrPSc through a process whereby some of its alpha-helical structure is converted into beta-sheet. The species of a particular prion is encoded by the sequence of the chromosomal PrP gene of the mammals in which it last replicated. In contrast to pathogens with a nucleic acid genome, prions encipher strain-specific properties in the tertiary structure of PrPSc. Transgenetic studies argue that PrPSc acts as a template upon which PrPC is refolded into a nascent PrPSc molecule through a process facilitated by another protein.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9442893     DOI: 10.1146/annurev.genet.31.1.139

Source DB:  PubMed          Journal:  Annu Rev Genet        ISSN: 0066-4197            Impact factor:   16.830


  29 in total

1.  Molecular modelling indicates that the pathological conformations of prion proteins might be beta-helical.

Authors:  D T Downing; N D Lazo
Journal:  Biochem J       Date:  1999-10-15       Impact factor: 3.857

2.  Pregnancy status and fetal prion genetics determine PrPSc accumulation in placentomes of scrapie-infected sheep.

Authors:  Wenbin Tuo; Katherine I O'Rourke; Dongyue Zhuang; William P Cheevers; Terry R Spraker; Donald P Knowles
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

3.  Changes in the middle region of Sup35 profoundly alter the nature of epigenetic inheritance for the yeast prion [PSI+].

Authors:  Jia-Jia Liu; Neal Sondheimer; Susan L Lindquist
Journal:  Proc Natl Acad Sci U S A       Date:  2002-12-02       Impact factor: 11.205

Review 4.  A brief history of prions.

Authors:  Mark D Zabel; Crystal Reid
Journal:  Pathog Dis       Date:  2015-10-07       Impact factor: 3.166

5.  New Molecular Insight into Mechanism of Evolution of Mammalian Synthetic Prions.

Authors:  Natallia Makarava; Regina Savtchenko; Irina Alexeeva; Robert G Rohwer; Ilia V Baskakov
Journal:  Am J Pathol       Date:  2016-02-09       Impact factor: 4.307

6.  Cell division modulates prion accumulation in cultured cells.

Authors:  Sina Ghaemmaghami; Puay-Wah Phuan; Beth Perkins; Julie Ullman; Barnaby C H May; Fred E Cohen; Stanley B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  2007-11-07       Impact factor: 11.205

7.  Proteasomal dysfunction and endoplasmic reticulum stress enhance trafficking of prion protein aggregates through the secretory pathway and increase accumulation of pathologic prion protein.

Authors:  Max Nunziante; Kerstin Ackermann; Kim Dietrich; Hanna Wolf; Lars Gädtke; Sabine Gilch; Ina Vorberg; Martin Groschup; Hermann M Schätzl
Journal:  J Biol Chem       Date:  2011-08-11       Impact factor: 5.157

Review 8.  Lysosomal Quality Control in Prion Diseases.

Authors:  Priyanka Majumder; Oishee Chakrabarti
Journal:  Mol Neurobiol       Date:  2017-04-18       Impact factor: 5.590

9.  A new mechanism for transmissible prion diseases.

Authors:  Natallia Makarava; Gabor G Kovacs; Regina Savtchenko; Irina Alexeeva; Valeriy G Ostapchenko; Herbert Budka; Robert G Rohwer; Ilia V Baskakov
Journal:  J Neurosci       Date:  2012-05-23       Impact factor: 6.167

10.  Preclinical deposition of pathological prion protein in muscle of experimentally infected primates.

Authors:  Susanne Krasemann; Melanie Neumann; Markus Geissen; Walter Bodemer; Franz-Josef Kaup; Walter Schulz-Schaeffer; Nathalie Morel; Adriano Aguzzi; Markus Glatzel
Journal:  PLoS One       Date:  2010-11-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.